(Q43159844)

15 November 2017

0 references

Osteopontin: an emerging therapeutic target in uraemic vascular disease (English)

1 reference

15 November 2017

4

Lilach O Lerman

1 reference

15 November 2017

3

Amir Lerman

1 reference

15 November 2017

2

Alfonso Eirin

1 reference

15 November 2017

Xin Zhang

1

1 reference

15 November 2017

23 April 2013

1 reference

15 November 2017

Cardiovascular Research

1 reference

15 November 2017

98

1 reference

15 November 2017

3

1 reference

15 November 2017

332-333

1 reference

Mechanisms of vascular calcification in chronic kidney disease

15 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Clinical and echocardiographic correlates of plasma osteopontin in the community: the Framingham Heart Study

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Non-traditional risk factors predict coronary calcification in chronic kidney disease in a population-based cohort

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E–Deficient Mice

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Osteopontin transgenic mice fed a high-cholesterol diet develop early fatty-streak lesions

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Phosphorus and uremic serum up-regulate osteopontin expression in vascular smooth muscle cells

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Angiotensin II directly increases transforming growth factor beta1 and osteopontin and indirectly affects collagen mRNA expression in the human heart.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3656615

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

15 August 2018

1 reference

12 December 2020

Osteopontin is expressed in human aortic valvular lesions

1 reference

12 December 2020

Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation

1 reference

12 December 2020

Smooth muscle cells deficient in osteopontin have enhanced susceptibility to calcification in vitro

1 reference

12 December 2020

Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells

1 reference

12 December 2020

Osteopontin deficiency dampens the pro-atherogenic effect of uraemia

1 reference

12 December 2020

Identifiers

DOI

10.1093/CVR/CVT098

1 reference

15 November 2017

1 reference

PMC publication ID

3656615

15 November 2017

PubMed publication ID

23612585

1 reference

PMC publication ID

3656615